vimarsana.com
Home
Live Updates
Inflammation Program Immune Modulation Section - Breaking News
Pages:
Latest Breaking News On - Inflammation program immune modulation section - Page 1 : vimarsana.com
OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development
/PRNewswire/ OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera.
United states
United kingdom
Kendall square
Christopher bahl
Michael krepps
Kukje pharma
Dennis klinman
National cancer institute
Inflammation program immune modulation section
Sx company
Dartmouth university
University of pennsylvania
Oncopep inc
University of maine
Institute for protein innovation
Tera science
OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development
/PRNewswire/ OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera.
United states
United kingdom
Kendall square
Christopher bahl
Michael krepps
Kukje pharma
Dennis klinman
National cancer institute
Inflammation program immune modulation section
Sx company
Dartmouth university
University of pennsylvania
Oncopep inc
University of maine
Institute for protein innovation
Tera science
vimarsana © 2020. All Rights Reserved.